BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: |
GlaxoSmithKline plc |
|||
Name of scheme: |
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan |
|||
Period of return: |
From: |
1 November 2017 |
To: |
30 April 2018 |
Balance of unallotted securities under scheme(s) from previous return: |
199,082 |
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
165,219 |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
33,863 |
|||
Name of contact: |
Victoria Whyte |
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: |
GlaxoSmithKline plc |
|||
Name of scheme: |
GlaxoSmithKline Share Option Plan - Ordinary Shares |
|||
Period of return: |
From: |
1 November 2017 |
To: |
30 April 2018 |
Balance of unallotted securities under scheme(s) from previous return: |
3,559,772 |
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
865,821 |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
2,693,951
|
|||
Name of contact: |
Victoria Whyte |
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: |
GlaxoSmithKline plc |
|||
Name of scheme: |
GlaxoSmithKline Share Option Plan - ADS |
|||
Period of return: |
From: |
1 November 2017 |
To: |
30 April 2018 |
Balance of unallotted securities under scheme(s) from previous return: |
8,185,120 |
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
275,126 |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
7,909,994 |
|||
Name of contact: |
Victoria Whyte |
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 May 2018
Name of applicant: |
GlaxoSmithKline plc |
|||
Name of scheme: |
GlaxoSmithKline plc Share Save Plan 2012 |
|||
Period of return: |
From: |
1 November 2017 |
To: |
30 April 2018 |
Balance of unallotted securities under scheme(s) from previous return: |
1,542,070 |
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
714,764 |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
827,306 |
|||
Name of contact: |
Victoria Whyte |
Telephone number of contact: |
020 8047 5000 |
The following GlaxoSmithKline plc Employee Share Schemes have expired and therefore will no longer be included in Block Listing Six Monthly Returns:
1. Glaxo Wellcome UK Share Option Scheme
2. Glaxo Wellcome International Share Option Scheme
3. Glaxo Wellcome 1999 Share Option Plan
4. SmithKline Beecham 1989 Executive Share Option Plan - Approved - Ordinary Shares
5. SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - ADS
6. SmithKline Beecham 1989 Executive Share Option Plan - Unapproved - Ordinary